BCLI Shares Outstanding History



Below is a table of the BCLI shares outstanding history going back to 8/4/2014:

Date BCLI Shares Outstanding
8/4/2014227.36M
9/16/20140.01B
9/30/201415.21M
11/4/201415.28M
3/23/201518.39M
5/11/201518.48M
8/10/201518.48M
3/4/201618.65M
5/6/201618.65M
8/8/201618.65M
11/7/201618.69M
3/24/201718.69M
5/5/201718.74M
8/7/201718.76M
10/13/201718.84M
3/6/201819.07M
4/30/201819.11M
6/30/201820.67M
10/25/201820.71M
3/28/201921.49M
5/1/201921.70M
8/7/201922.55M
8/30/20194.67M
11/6/201922.61M
2/14/202026.23M
5/4/202029.44M
7/31/202031.53M
9/30/202031.57M
2/4/202135.72M
4/23/202136.32M
8/5/202136.32M
11/15/202136.28M
3/28/202236.49M
5/10/202236.49M
8/15/202236.49M
11/14/202236.54M
3/28/202336.68M
5/15/202339.41M
8/14/202345.02M
11/10/202348.98M
3/27/202468.34M

Also see: BCLI Market Cap History
BCLI YTD Return
BCLI Historical Shares Outstanding:
-11.71% CAGR
BCLI Historical Shares Outstanding: +-11.71% CAGR

Mouse over chart for data details
8/4/2014 ...3/27/2024
BrainStorm Cell Therapeutics is a biotechnology company engaged in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases including: Amyotrophic Lateral Sclerosis; Progressive Multiple Sclerosis; Alzheimer's disease; and other neurodegenerative diseases. NurOwn®, Co.'s proprietary cell therapy platform, utilizes cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. We show 41 historical shares outstanding datapoints in our coverage of BCLI's shares outstanding history.

Understanding the changing numbers of BCLI shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BCLI versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BCLI by allowing them to research BCLI shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree BCLI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Brainstorm Cell Therapeutics (BCLI) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

BCRX Shares Outstanding History
BDSI Shares Outstanding History
BDSX Shares Outstanding History
BDTX Shares Outstanding History
BDX Shares Outstanding History
BEAM Shares Outstanding History
BEAT Shares Outstanding History
BFLY Shares Outstanding History
BFRG Shares Outstanding History
BFRI Shares Outstanding History
More Healthcare companies »

 

BCLI Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.